Physician profile
Kerry Corcoran
NPI 1821860412
$3,170.91
in general payments reported to CMS, 2019-2025
19 companies · $1,852 in 2025
The $1,852 reported for 2025 was more than what 94% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $165 · 2024: $1,154 · 2025: $1,852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,170.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $405.03 | 2024-2025 | Verquvo, Lagevrio, Capvaxive |
| E.R. Squibb & Sons, L.L.C. | $366.48 | 2024-2025 | Camzyos, Eliquis |
| Novo Nordisk INC | $341.38 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $309.56 | 2024-2025 | Repatha, Repatha |
| Esperion Therapeutics, INC. | $254.58 | 2023-2025 | Nexletol |
| Alnylam Pharmaceuticals INC. | $244.27 | 2024-2025 | Onpattro, Amvuttra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $216.25 | 2024-2025 | Jardiance |
| Pfizer INC. | $166.99 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $162.16 | 2023-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $149.33 | 2024-2025 | Farxiga, Lokelma |
| Scpharmaceuticals INC. | $134.00 | 2025 | |
| Bridgebio Pharma, INC. | $119.89 | 2025 | Attruby |
| Lexicon Pharmaceuticals, INC. | $118.08 | 2023-2024 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $47.24 | 2025 | |
| Abiomed | $45.79 | 2024 | Impella |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $30.29 | 2024 | Evkeeza |
| Philips North America LLC | $23.80 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Boston Scientific Corporation | $20.60 | 2023 | Lux-Dx Insertable Cardiac Monitor |
| Vivaquant INC, Dba Rhythm Express | $15.19 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Corcoran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.